BiotechTube

NexoBrid

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Thermal Burns

Conditions

Thermal Burns

Trial Timeline

May 1, 2015 → Dec 1, 2022

NCT ID
NCT02278718

About NexoBrid

NexoBrid is a phase 3 stage product being developed by MediWound for Thermal Burns. The current trial status is completed. This product is registered under clinical trial identifier NCT02278718. Target conditions include Thermal Burns.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT04040660Pre-clinicalCompleted
NCT02278718Phase 3Completed

Competing Products

4 competing products in Thermal Burns

See all competitors
ProductCompanyStageHype Score
R475 + PlaceboSanofiPhase 2
51
cP12United TherapeuticsPhase 2
49
NexoBridMediWoundPre-clinical
15
NexoBrid + Gel VehicleMediWoundPhase 3
69

Other Products from MediWound

NexoBrid + Gel VehiclePhase 3
69
EscharEx (EX-03) + Placebo (Gel vehicle)Phase 3
69
DGDPhase 3
69
EscharEx (5% EX-02 formulation) + Gel Vehicle + Non-surgical standard of care (NSSOC)Phase 2
44
EscharEx + Gel VehiclePhase 2
44